Hexadecylphosphocholine-mediated enhancement of T-cell responses to interleukin 2
- 1 October 1991
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 137 (1), 232-238
- https://doi.org/10.1016/0008-8749(91)90072-j
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1990
- Ether lipid (AMG) exhibits both synergistic and inhibitory interactions with the ionophore A23187 in mast cell histamine releaseImmunopharmacology, 1990
- Cytotoxic Activity of Lysophosphatidylcholine Analogues on Human Lymphoma Raji CellsOncology Research and Treatment, 1990
- Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteinsCell, 1989
- Membrane damage in leukemic cells induced by ether and ester lipids: An electron microscopic studyExperimental and Molecular Pathology, 1989
- Hexadecylphosphocholine, a New Ether Lipid Analogue Studies on the Antineoplastic Activity in Vitro and in VivoActa Oncologica, 1988
- Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)European Journal of Cancer and Clinical Oncology, 1988
- Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasionLipids, 1987
- Antileukemic effect of alkyl phospholipidsCancer Chemotherapy and Pharmacology, 1983
- The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinomaEuropean Journal of Cancer (1965), 1980